Pharmafile Logo
Pharmafocus logo
Advanced Search
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

October 7, 2020
Research and Development COVID, COVID-19, corornavirus

The coronavirus news this week focuses on treatments, with Enlivex Therapeutics releasing positive data for its therapy Allocetra as a …

News
bel-n-garijo-large

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO

October 6, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …

Appointment
headache

Aimovig reduces frequency of episodic migraines, five-year data reveals

October 6, 2020
Manufacturing and Production, Research and Development Aimovig

Amgen and Novartis have revealed new five-year Phase 2 data during the Migraine Trust Virtual Symposium for their calcitonin gene-related …

News
800px-nhs_nnuh_entrance

NHS warns that UK could face drugs shortages after Brexit stockpile has been used to fight COVID-19

October 6, 2020
Manufacturing and Production

The NHS has warned that hospitals could face shortages of drugs during the second wave of coronavirus due to the …

News
fda2outsideweb

Opdivo/Yervoy combo secures FDA approval for malignant pleural mesothelioma

October 6, 2020
Manufacturing and Production, Research and Development Bristol-Myers Squibb, Yervoy, bristol myers squibb, opdivo

Bristol Myers Squibb’s therapy regimen of Opdivo (nivolumab) in combination with Yervoy (ipilimumab) has secured FDA approval for the first-line …

News
fda_21_4_1

White House halts release of new FDA standards for the Emergency Use Authorization of COVID-19 vaccine

October 6, 2020
Manufacturing and Production FDA, Trump, Vaccine, coronavirus vaccines

The Trump White House is blocking new federal guidance for the emergency release of coronavirus vaccines that would essentially ensure …

News
4353113087_4d19c3a402_b_1

Bristol Myers Squibb agrees $13 billion deal to acquire MyoKardia

October 6, 2020
Manufacturing and Production BSM, FDA, MyoKardia

Bristol Myers Squibb (BMS) is to purchase MyoKardia for $13 billion to boost its heart disease treatments portfolio. The deal …

News
shutterstock_138095450

Alivio Therapeutics receives $3.3m from US Department of Defense to support development of IBD drug candidate

October 5, 2020
Research and Development, Sales and Marketing Alivio, US, ibd, pharma

The US Department of Defense (DoD) has committed a Technology/Therapeutic Development Award to the value of $3.3 million to biotech …

News
shutterstock_212432119

ViiV’s two-drug regimen proves non-inferior in treatment-naive HIV-1

October 5, 2020
Research and Development, Sales and Marketing HIV-1, ViiV Healthcare, pharma

ViiV Healthcare has taken the opportunity at the HIV Glasgow 2020 Virtual Congress to unveil three-year Phase 3 data from …

News

FDA defies advisory panel recommendation, rejecting Mesoblast’s Ryoncil in paediatric steroid-refractory acute graft versus host disease

October 5, 2020
Sales and Marketing FDA, Mesoblast, Ryoncil

The FDA has issued a surprising rejection of Mesoblast’s Ryoncil (remestemcel-L) as a treatment for paediatric steroid-refractory acute graft versus …

News
shutter

Remdesivir has a “favourable” benefit/risk profile in COVID-19 but more data needed, DSRU review argues

October 5, 2020
Research and Development, Sales and Marketing COVID-19, Drug Safety Research Unit, pharma, remdesivir

Southampton’s Drug Safety Research Unit (DSRU) has released a systematic benefit/risk analysis of Gilead’s antiviral drug remdesivir in the treatment …

News
shutterstock_273326141

Covis Group to acquire AMAG Pharmaceuticals in $647m deal

October 5, 2020
Sales and Marketing AMAG Pharmaceuticals, Covis group, acquisition, pharma

Luxembourg-based Covis Group is set to acquire Massachusetts-based AMAG Pharmaceuticals in a new deal worth approximately $647 million on an …

News
banner

Across Health to hold first iD.cast webcast ‘Digital Acceleration in Biopharma’ on 15 October

October 2, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, event

Across Health is hosting its first iD.cast webcast, titled Digital Acceleration in Biopharma on 15 October. This ninety-minute webinar online …

News
vaccination-1215279_960_720

IGT Biologika’s COVID-19 vaccine becomes third in Germany to be approved for human trials

October 2, 2020
Medical Communications, Research and Development COVID-19, IDT Biologika, Vaccine

German biotech IDT Biologika has become the third company in the country to secure approval from the nation’s vaccine regulator …

News
800px-astrazeneca_hq_in_cambridge_uk_1

AstraZeneca’s COVID-19 vaccine trials resume in Japan but still on hold in US

October 2, 2020
Medical Communications COVID, coronavirus

AstraZeneca’s experimental coronavirus vaccine has resumed clinical trials in Japan after a patient illness halted the global study, but the …

News
donald_and_melania_trump

Donald and Melania Trump test positive for COVID-19

October 2, 2020
Medical Communications COVID-19, Trump, coronavirus

President Donald Trump and First Lady Melania Trump have both tested positive for COVID-19.  Trump tweeted: “Tonight, @FLOTUS and I …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

October 2, 2020
Medical Communications

The top ten news stories this week focus on vaccines and treatments, with allegations Russia is sowing disinformation about COVID-19 …

News
novartis_outside_1

Novartis unveils strong Phase 3 efficacy for one-time therapy Zolgensma in paediatric spinal muscular atrophy

October 1, 2020
Research and Development Novartis, Zolgensma, spinal muscular atrophy

Novartis has lifted the curtain on new Phase 3 data from an ongoing trial of 33 participants on the efficacy …

News
shutterstock_38078521

Enlivex’s Allocetra improves COVID-19 recovery times, early data show

October 1, 2020
Research and Development Allocetra, Enlivex

Israeli immunotherapy firm Enlivex Therapeutics has released tentatively positive data for its therapy Allocetra as a treatment for patients with …

News
800px-healthcare_workers_wearing_ppe_03

Coronavirus transmission in India driven by superspreaders

October 1, 2020
Research and Development

India’s largest contract tracing study has found that the virus has been transmitted through ‘super spreaders.’ The study was conducted …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026